Mezzion Pharma Co.Ltd (140410) — Capital Reinvestment Ratio
Latest as of September 2023:
1.15x
Mezzion Pharma Co.Ltd (140410) has a Capital Reinvestment Ratio of 1.15x as of September 2023, meaning it reinvests 1% of its operating cash flow (₩4.73 Billion) in capital expenditures (₩5.46 Billion). See 140410 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.15x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.73 Billion
KRW
Capital Expenditures
₩5.46 Billion
KRW
Data as of
Sep 2023
Most recent filing
Mezzion Pharma Co.Ltd Capital Reinvestment Ratio (2012–2015)
This chart tracks Mezzion Pharma Co.Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Mezzion Pharma Co.Ltd (2012–2015)
Year-by-year Capital Reinvestment Ratio for Mezzion Pharma Co.Ltd from 2012 to 2015. For live market cap and broader valuation context, see 140410 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.32x | ₩1.77 Billion | ₩564.10 Million | ▲ +77.0% |
| 2012 | 0.18x | ₩3.14 Billion | ₩564.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow